News

IntelyCare Launches First COVID-19 Training Program for Nurses, Nursing Facilities to Help Mitigate Spread of Virus

IntelyCare Launches First COVID-19 Training Program for Nurses, Nursing Facilities to Help Mitigate Spread of Virus Free Virtual Training Offered to Meet Growing Demand from Most Vulnerable Healthcare Segment for Increased Education and Support QUINCY, MA – March 17, 2020 – In response to the global COVID-19 pandemic, [...]

2020-03-18T16:12:31+00:00March 18th, 2020|All News, Company News|

Endeavour Vision leads investment in Intelycare’s artificial intelligence-driven nurse staffing platform, to support the next phase of the company’s growth

Endeavour Vision leads investment in Intelycare’s artificial intelligence-driven nurse staffing platform, to support the next phase of the company’s growth Geneva, February 20, 2020 - Endeavour Vision led the Series B funding round for Boston-based IntelyCare, along with Kaiser Permanente Ventures and Generator Ventures, allowing the company to [...]

2020-02-20T18:22:04+00:00February 20th, 2020|All News, Company News|

IntelyCare Completes Largest Venture Round in Nursing; Raises $45M to Solve Nationwide Workforce Shortage

IntelyCare Completes Largest Venture Round in Nursing; Raises $45M to Solve Nationwide Workforce Shortage Endeavour Vision, Kaiser Permanente Ventures, and Generator Ventures Join Existing Investors in Round, Leveraging Gig Economics to Close Projected 1 Million Nurse Shortfall by 2030; Builds on Company’s Exceptional Momentum QUINCY, MA – February [...]

2020-02-20T14:06:24+00:00February 20th, 2020|All News, Company News|

Molecular Partners Receives Orphan Drug Designation for MP0250 for Multiple Myeloma

Molecular Partners Receives Orphan Drug Designation for MP0250 for Multiple Myeloma Zurich-Schlieren, Switzerland, December 27, 2019. Molecular Partners AG (SIX:MOLN), a clinical stage biotech company pioneering the use of DARPin® therapeutics to treat serious diseases, announces the receipt of Orphan Drug Designation by the US Food and Drug [...]

2020-01-06T14:14:02+00:00January 6th, 2020|All News, Company News|

Interview with Bradley Paddock, CEO of CeQur

Interview with Bradley Paddock, CEO of CeQur In June 2019, Bradley Paddock joined CeQur®, as Chief Executive Officer. We spoke to Bradley to hear about his first 6 months in the company and discuss the up-coming U.S. launch of its three-day insulin delivery device for type 2 diabetes.  [...]

2020-01-06T11:51:06+00:00January 6th, 2020|All News, Blog|

Gynesonics Announces Full Launch of New Sonata 2 System at 48th AAGL Global Congress

Gynesonics Announces Full Launch of New Sonata 2 System at 48th AAGL Global Congress 2-year Outcomes Data from the SONATA IDE Pivotal Trial To Be Presented, Demonstrating Significant and Sustained Symptom Relief REDWOOD CITY, Calif. - November 11, 2019 - Gynesonics, a women’s healthcare company focused on the development [...]

2019-11-29T16:01:15+00:00November 12th, 2019|All News, Company News|

Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational Abicipar pegol in Neovascular Wet Age-Related Macular Degeneration

Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational Abicipar pegol in Neovascular Wet Age-Related Macular Degeneration Two-year results from CEDAR and SEQUOIA demonstrate that vision gains observed after one year with every 8-week and every 12-week dosing were maintained in the second year Abicipar [...]

2019-10-22T11:02:49+01:00October 14th, 2019|All News, Company News, Previous Sectors|
Go to Top